Who is the CEO of Astonea Labs Ltd?
- Answer Field
-
The CEO of Astonea Labs Ltd. is Ashish Gulati.
BAJAJ BROKING
Astonea Labs Ltd., incorporated in 2017, operates as a contract manufacturer catering to the pharmaceutical and cosmetic sectors, serving both domestic and international clients. The company specialises in a wide range of formulations, including antibiotics, anti-cold medicines, antihistamines, and treatments for conditions such as diabetes, cardiovascular diseases, gynaecological concerns, and infections. Alongside medicinal products, Astonea Labs offers personal care solutions for skin, dental, and hair care—available in formats like creams, gels, serums, oils, ointments, and lotions. These products are developed to meet industry quality standards, reinforcing the company’s focus on safety and compliance.
In addition to contract manufacturing, Astonea Labs markets its own brands—“Glow Up” and “Regero”—in the Indian market, with plans to introduce another brand, “Avicel.” The company also exports to countries such as Iraq and Yemen, while engaging in the trade of packaging and raw materials relevant to its core industries. This diversified operational approach positions Astonea Labs as a noteworthy player in the healthcare and personal care manufacturing space.
For more details, visit the Astonea Labs IPO page.
Details | Information |
IPO Date | May 27, 2025 to May 29, 2025 |
Issue Size | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
Price Band | ₹128 to ₹135 per share |
Lot Size | 1000 shares |
Listing At | BSE SME |
Purpose of the IPO
Funding of expenses proposed to be incurred towards registration in Bolivia, South America
Purchase and Installation of plants and machineries on the 2nd floor of existing premises of the factory i.e., Haripur, Tehsil – Raipur Rani, District Panchkula, Haryana (“Existing Premises”), for ointment plant as per USFDA guidelines for export purposes
Advertising, marketing and brand building
Investment in procuring hardware and software
Funding for working Capital requirements
General corporate purposes
Event | Date |
---|---|
IPO Open Date | Tue, May 27, 2025 |
IPO Close Date | Thu, May 29, 2025 |
Tentative Allotment | Fri, May 30, 2025 |
Initiation of Refunds | Mon, Jun 2, 2025 |
Credit of Shares to Demat | Mon, Jun 2, 2025 |
Tentative Listing Date | Tue, Jun 3, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on May 29, 2025 |
Price Band for the IPO
₹128 to ₹135 per share
Minimum Lot Size and Application Details
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 1000 | ₹1,35,000 |
Retail (Max) | 1 | 1000 | ₹1,35,000 |
HNI (Min) | 2 | 2,000 | ₹2,70,000 |
Online Application Process
Log in to Your Trading Account
Access your trading account through your broker’s platform.
Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Select Astonea Labs IPO
Find "Astonea Labs IPO" and click on the ‘Apply’ button.
Enter Application Details
Specify the number of lots (minimum lot size: 1000 shares) and the bid price within the range of ₹128 to ₹135 per share.
Provide Your UPI ID
Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit
Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on May 29, 2025, to complete your application process.
Key Financial Metrics
Total Assets: Grew from ₹52.91 crore in FY22 to ₹96.52 crore as of December 2024.
Revenue: Reached ₹69.69 crore in FY24.
Profit After Tax (PAT): Stood at ₹4.10 crore for December 2024.
Net Worth: Increased from ₹7.49 crore in FY22 to ₹17.28 crore as of December 2024.
Reserves and Surplus: Recorded at ₹9.56 crore (Dec 2024), growing steadily over the years.
Total Borrowings: Stood at ₹49.48 crore in December 2024.
Recent Performance and Growth Prospects
The company has shown a steady rise in its asset base, reflecting ongoing business expansion and operational scaling.
Revenue generation has progressed consistently, indicating strong market demand and effective sales execution.
Profitability has improved over time, highlighting better cost management and operational efficiency.
The company's net worth has strengthened, suggesting improved financial stability and shareholder value creation.
Reserves and surplus have seen healthy growth, pointing to reinvestment capability and retained earnings.
While borrowings have increased, it suggests the business is leveraging capital to support its growth and expansion initiatives.
Potential Risks of Investing in the IPO
The company’s presence in international markets such as Iraq and Yemen may expose it to geopolitical and regulatory uncertainties, potentially affecting export operations.
Increased borrowings and upcoming capital expenditure for expansion and compliance could place short-term pressure on liquidity and financial flexibility.
Opportunities and Growth Potential
Astonea Labs Ltd established manufacturing base, experienced leadership, and consistent expansions offer strong potential for scaling operations in the growing packaging and specialty paper segments.
The IPO funding aims to boost capacity through a power plant and meet working capital needs, enabling operational efficiency and positioning the company for long-term sustainable growth.
KPI | Values |
ROE | 37.86% |
ROCE | 22.95% |
Debt/Equity | 2.16 |
RoNW | 31.83% |
PAT Margin | 4.75 |
Price to Book Value | 8.57 |
Registrar | Lead Manager(s) |
---|---|
Kfin Technologies Limited | Oneview Corporate Advisors Pvt. Ltd. |
Astonea Labs Ltd
House No. 1358,
1st Floor,
Sector-22B,
Phone: +91 9888302323
Email: cs@astonea.org
Website: https://www.astonea.org/
Astonea Labs Ltd. operates across pharmaceutical and personal care segments through contract manufacturing and its own product brands. Its business activities span domestic and international markets, with an emphasis on compliance, product variety, and expansion of manufacturing capacity. The company’s involvement in packaging and raw material trade adds to its operational scope.
The IPO proceeds are intended to support activities including plant installation, brand marketing, working capital, and regulatory registrations. These steps align with the company's objective to scale operations in both local and export markets.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Astonea Labs IPO.
Share this article:
No result found
The CEO of Astonea Labs Ltd. is Ashish Gulati.
The Astonea Labs IPO will open for subscription on May 27, 2025, and will close on May 29, 2025.
Astonea Labs Ltd. operates as a contract manufacturer in the pharmaceutical and cosmetic sectors, offering a wide range of formulations and personal care products. It also markets its own brands and exports to select countries. Its diversified product portfolio, domestic and international presence, and integration of raw material and packaging trades contribute to the sustainability of its business model, subject to market dynamics and regulatory environments.
The issue size is 27,90,000 shares, aggregating up to approximately ₹37.67 crore.
‘Pre-apply’ allows investors to submit IPO applications before the official opening date. These applications are processed once the IPO opens for subscription, helping investors avoid last-minute rush.
You will receive a confirmation once the UPI mandate is approved and the broker/platform successfully submits your application to the exchange. It is important to approve the UPI mandate by 5 PM on May 29, 2025.
The minimum lot size is 1, which consists of 1000 shares. The minimum application amount for retail investors is ₹1,35,000.
The tentative allotment date is May 30, 2025.
The registrar for the IPO is Kfin Technologies Limited.
As per available public disclosures and IPO documents, no governance issues or red flags have been reported in relation to the company’s leadership or board structure.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading